Philips launches updated therapeutic hypothermia system
This article was originally published in The Gray Sheet
Executive Summary
Philips Healthcare debuts its InnerCool RTx endovascular system for therapeutic patient cooling and warming March 29 following 510(k) clearance in the U.S. and CE-mark approval in Europe. The next-generation system features updates to the firm's InnerCool, including a graphical user interface with touch panel and color and ergonomic design characteristics for the console. The system is designed to induce, maintain and reverse mild hypothermia in certain neurosurgical and cardiac surgery patients in recovery or intensive care. The company previously announced that it would launch an international clinical trial of the technology for ischemic stroke patients at the end of April (1"The Gray Sheet" March 22, 2010)